Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cholecalciferol in Patients With Hypertension
NCT01166165Phase 2Completed
- Sponsor
- Regionshospitalet Holstebro
- Start
- Jul 2010
- Primary completion
- Apr 2011
- Modality
- Orthosteric Ligands, Metabolically Activated Prodrugs
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of vitamin d in hypertension (HTN), sponsored by Regionshospitalet Holstebro. Primary endpoint: 24-hour systolic blood pressure at 20 weeks. Started Jul 2010; status: completed.
02
Drugs
vitamin d
03
Conditions
hypertension (HTN)
Beyond the preview
Go deeper on NCT01166165.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01166165.